<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1409-0015</journal-id>
<journal-title><![CDATA[Medicina Legal de Costa Rica]]></journal-title>
<abbrev-journal-title><![CDATA[Med. leg. Costa Rica]]></abbrev-journal-title>
<issn>1409-0015</issn>
<publisher>
<publisher-name><![CDATA[Asociación Costarricense de Medicina Forense]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1409-00152016000200012</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Alteración de los analitos medibles del síndrome metabólico en el laboratorio clínico en pacientes de consulta externa del cantón de Guápiles en el año 2015]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvajal Carvajal]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital de Guápiles Laboratorio Clínico ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>33</volume>
<numero>2</numero>
<fpage>12</fpage>
<lpage>19</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S1409-00152016000200012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S1409-00152016000200012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S1409-00152016000200012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Justificación:  Conocer el nivel de alteración de los componentes del síndrome metabólico en la población permite evaluar el riesgo de desarrollar diabetes mellitus tipo 2 y enfermedades cardiovasculares.  Objetivo:  Comparar los valores sanguíneos de tres analitos del síndrome metabólico (triglicéridos, glucosa y colesterol HDL) en adultos de ambos sexos de Consulta Externa del Hospital de Guápiles, en el año 2015, con respecto a los valores de referencia según la NCEP ATP III.  Métodos:  Se tomaron valores de glucosa, triglicéridos y colesterol HDL de la base de datos del Laboratorio del Hospital de Guápiles, del año 2015. Luego se procedió a determinar por sexo, por grupo de edad y en forma combinada (hombres y mujeres) la alteración, absoluta y porcentual, de cada analito con respecto a los valores de referencia de la NCEP ATP III. Además, se determinó el perfil de alteración (frecuencia absoluta y porcentaje) por sexo, por grupo de edad y combinado.  Resultados:  En las mujeres el HDL-C es el parámetro más alterado, con un 75.3 por ciento de las pacientes teniéndolo disminuido. Lo mismo sucede analizando por grupo de edad. En los hombres el parámetro más alterado es también el HDL-C (60.1 por ciento), seguido de los triglicéridos (53.8 por ciento). En las mujeres la alteración únicamente del HDL-C es la situación más común (31.1 por ciento), seguida de la alteración conjunta de TRG-HDL-C (22.6 por ciento). En los hombres la situación se invierte: la alteración de TRG-HDL-C es la más frecuente (25.4 por ciento), seguida de la de HDL-C (13.8 por ciento).  Discusión:  Los parámetros que más se alteraron fueron los lipídicos. Además, conforme aumentaba la edad se incrementaban el porcentaje de valores alterados y el porcentaje de pacientes con los tres analitos alterados. El aumento del sedentarismo, del sobrepeso y de la obesidad con la edad ayuda a explicar este fenómeno.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Justification:  Knowing the degree of alteration in the metabolic syndrome&#8217;s components within the target population allows us to evaluate the risk of developing type 2 diabetes mellitus and cardiovascular diseases.  Objective:  To compare the blood values of three analytes of the metabolic syndrome (triglycerides, glucose, and HDL cholesterol) taken from adult outpatients from Hospital de Guápiles, from both sexes, during the year 2015, in accordance to the reference values of NCEP ATP III.  Methods:  Glucose, triglycerides, and HDL cholesterol values were taken from Hospital de Guápiles&#8217; Laboratory, belonging to the year 2015. The absolute and percentage alteration of each analyte was determined according to sex, age group, as well as in a joint manner (both men and women), following the reference values of NCEP ATP III. The alteration profile (absolute frequency and percentage) was also determined according to sex, age group, and in a joint manner.  Results:  HDL-C in women is the most altered parameter, with a 73 por ciento of the patients exhibiting it diminished. The same occurs when analyzing it by age group. In men the most altered parameter is also HDL-C (60.1 por ciento), followed by triglycerides (53.8 por ciento). The most common situation for women is the exclusive alteration of HDCL-C (3.1 por ciento), followed by the joint alteration of TRG-HDL-C (22.6 por ciento). For men it is rather the opposite: TRG-HDL-C is the most frequent (25.4), being followed by HDL-C (13-8 por ciento).  Discussion:  The most altered parameters were lipids. Also, as the age increased, so did the percentage of altered values, as well as the percentage of patients who had the three analytes altered. The age-related increase of a sedentary lifestyle, and overweight condition and obesity helps to explain this phenomenon.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Síndrome metabólico]]></kwd>
<kwd lng="es"><![CDATA[triglicéridos]]></kwd>
<kwd lng="es"><![CDATA[HDL-colesterol]]></kwd>
<kwd lng="en"><![CDATA[Metabolic syndrome]]></kwd>
<kwd lng="en"><![CDATA[triglycerides]]></kwd>
<kwd lng="en"><![CDATA[colesterol HDL]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance]]></source>
<year>2012</year>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vykoukal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vascular biology of metabolic syndrome]]></article-title>
<source><![CDATA[J Vasc Surg]]></source>
<year>2011</year>
<volume>54</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>819-31</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaur]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comprehesive review on metabolic syndrome]]></article-title>
<source><![CDATA[Cardiology Research and Practice]]></source>
<year>2014</year>
<page-range>1-21</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Niemi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Solomon]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Haus]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Filion]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exercise training with weight loss and either a high or low glycemic diet reduces metabolic syndrome severity in older adults]]></article-title>
<source><![CDATA[Ann Nutr Metab]]></source>
<year>2012</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>135-41</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hutcheson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rocic]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The metabolic syndrome, oxidative stress environment, and cardiovascular disease: the great exploration]]></article-title>
<source><![CDATA[Experimental Diabetes Research]]></source>
<year>2012</year>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Aqeedi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Adullatef]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Dabdoob]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bener]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Albinali]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gehani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevalence of metabolic syndrome components, individually and in combination, in male patients admitted with acute coronary syndrome, without previous diagnosis of diabetes mellitus]]></article-title>
<source><![CDATA[Libyan J Med]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[J. A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J. H]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[S. Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ha]]></surname>
<given-names><![CDATA[H. S]]></given-names>
</name>
<name>
<surname><![CDATA[Kwon]]></surname>
<given-names><![CDATA[H. S]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[Y. M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness]]></article-title>
<source><![CDATA[J Diabetes Investigation]]></source>
<year>2013</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>334-43</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khoo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding the metabolic syndrome]]></article-title>
<source><![CDATA[Rev Biomed Eng]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>143-55</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Reviriego]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program and International Diabetes Federation definitions. Diabetes, Metabolic Syndrome and Obesity]]></article-title>
<source><![CDATA[targets and Therapy]]></source>
<year>2011</year>
<volume>4</volume>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prasad]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome and chronic kidney disease: current status and future directions]]></article-title>
<source><![CDATA[World J Nephrol]]></source>
<year>2014</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>210-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[D. L]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J. H]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults]]></article-title>
<source><![CDATA[J Geriatrics Cardiology]]></source>
<year>2012</year>
<volume>9</volume>
<page-range>123-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parikh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mohan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Changing definitions of metabolic syndrome]]></article-title>
<source><![CDATA[Indian J Endocrinol and Metabolism]]></source>
<year>2015</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-13</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico en pacientes diabéticos tipo 2 e intolerantes a carbohidratos del EBAIS La Mansión, Nicoya]]></article-title>
<source><![CDATA[Acta Médica Costarricense]]></source>
<year>2003</year>
<volume>45</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>154-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quirós]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Solís]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico: ¿un elefante en una caja?]]></article-title>
<source><![CDATA[Revista Costarricense de Cardiología]]></source>
<year>2006</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>19-23</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[A.T]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[M. I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad cardiovascular en Costa Rica]]></article-title>
<source><![CDATA[Costarricense de Salud Pública]]></source>
<year>2006</year>
<volume>15</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kringle]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statistical Procedures]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Burtis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Tietz Textbook of clinical chemistry]]></source>
<year>1994</year>
<edition>2</edition>
<page-range>384-453</page-range><publisher-loc><![CDATA[USA ]]></publisher-loc>
<publisher-name><![CDATA[WB Saunders Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bradshaw]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Monda]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stevens]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome in healthy obese, overweight and normal weight individuals: the atherosclerosis risk in communities study]]></article-title>
<source><![CDATA[Obesity]]></source>
<year>2013</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>203-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balkau]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Valensi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Eschwège]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Slama]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of metabolic syndrome]]></article-title>
<source><![CDATA[Diabetes &amp; Metabolism]]></source>
<year>2007</year>
<volume>33</volume>
<page-range>405-13</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kassi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pervanidou]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Kaltsas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chrousos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome: definitions and controversies]]></article-title>
<source><![CDATA[BMC Medicine]]></source>
<year>2011</year>
<volume>9</volume>
<numero>48</numero>
<issue>48</issue>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Biino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Concas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cena]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Parracciani]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vaccargiu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cosso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate]]></article-title>
<source><![CDATA[SpringerPlus]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sperling]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mechanick]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Neeland]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Herrick]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Després]]></surname>
<given-names><![CDATA[J. P]]></given-names>
</name>
<name>
<surname><![CDATA[Ndumele]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The cardiometabolic health Alliance]]></article-title>
<source><![CDATA[J Am College Cardiology]]></source>
<year>2015</year>
<volume>66</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1050-67</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
